Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19
Sebastiano Bruno Solerte, Antonio Di Sabatino, Massimo Galli, et al.
Acta Diabetologica (2020) Vol. 57, Iss. 7, pp. 779-783
Open Access | Times Cited: 198

Showing 1-25 of 198 citing articles:

Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections?
Varnica Bajaj, Nirupa Gadi, Allison P. Spihlman, et al.
Frontiers in Physiology (2021) Vol. 11
Open Access | Times Cited: 433
Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection
Laura Montefusco, Moufida Ben Nasr, Francesca D’Addio, et al.
Nature Metabolism (2021) Vol. 3, Iss. 6, pp. 774-785
Open Access | Times Cited: 360
Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study
Sebastiano Bruno Solerte, Francesca D’Addio, Roberto Trevisan, et al.
Diabetes Care (2020) Vol. 43, Iss. 12, pp. 2999-3006
Open Access | Times Cited: 223
COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course
Cyril P. Landstra, Eelco J.P. de Koning
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 178
Flavonoids against the SARS-CoV-2 induced inflammatory storm
Alena Líšková, Marek Samec, Lenka Koklesová, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 138, pp. 111430-111430
Open Access | Times Cited: 136
Can SARS-CoV-2 Virus Use Multiple Receptors to Enter Host Cells?
Laura Kate Gadanec, Kristen Renee McSweeney, Tawar Qaradakhi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 992-992
Open Access | Times Cited: 134
Post-acute sequelae of COVID-19: A metabolic perspective
Philipp E. Scherer, John P. Kirwan, Clifford J. Rosen
eLife (2022) Vol. 11
Open Access | Times Cited: 76
Evidence for Biological Age Acceleration and Telomere Shortening in COVID-19 Survivors
Alessia Mongelli, Veronica Barbi, Michela Gottardi Zamperla, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 6151-6151
Open Access | Times Cited: 91
PD-1 blockade counteracts post–COVID-19 immune abnormalities and stimulates the anti–SARS-CoV-2 immune response
Cristian Loretelli, Ahmed Abdelsalam, Francesca D’Addio, et al.
JCI Insight (2021) Vol. 6, Iss. 24
Open Access | Times Cited: 70
Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach
Zahra Molavi, Sara Razi, Seyed Amir Mirmotalebisohi, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 138, pp. 111544-111544
Open Access | Times Cited: 63
Diabetes, Drug Treatment, and Mortality in COVID-19: A Multinational Retrospective Cohort Study
Jennifer E. Nyland, Nazia Raja‐Khan, Kerstin Bettermann, et al.
Diabetes (2021) Vol. 70, Iss. 12, pp. 2903-2916
Open Access | Times Cited: 63
Endothelial Immunity Trained by Coronavirus Infections, DAMP Stimulations and Regulated by Anti-Oxidant NRF2 May Contribute to Inflammations, Myelopoiesis, COVID-19 Cytokine Storms and Thromboembolism
Ying Shao, Jason Saredy, Keman Xu, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 57
Races of small molecule clinical trials for the treatment of COVID‐19: An up‐to‐date comprehensive review
Suwen Hu, Songwei Jiang, Qi Xiang, et al.
Drug Development Research (2021) Vol. 83, Iss. 1, pp. 16-54
Open Access | Times Cited: 56
Diabetes and COVID-19: Short- and Long-Term Consequences
Charlotte Steenblock, Mohamed Hassanein, Emran G. Khan, et al.
Hormone and Metabolic Research (2022) Vol. 54, Iss. 08, pp. 503-509
Open Access | Times Cited: 51
SARS-CoV-2 infects human brain organoids causing cell death and loss of synapses that can be rescued by treatment with Sofosbuvir
Pinar Mesci, Janaína Sena de Souza, Laura Martin‐Sancho, et al.
PLoS Biology (2022) Vol. 20, Iss. 11, pp. e3001845-e3001845
Open Access | Times Cited: 45
Human Brain Microvascular Endothelial Cells Exposure to SARS-CoV-2 Leads to Inflammatory Activation through NF-κB Non-Canonical Pathway and Mitochondrial Remodeling
Carolline Soares Motta, Silvia Torices, Bárbara Gomes da Rosa, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 745-745
Open Access | Times Cited: 28
Signaling pathways and intervention for therapy of type 2 diabetes mellitus
Rong Cao, Huimin Tian, Yu Zhang, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 24
Potential Anti-COVID-19 Therapeutics that Block the Early Stage of the Viral Life Cycle: Structures, Mechanisms, and Clinical Trials
Rami A. Al‐Horani, Srabani Kar, Kholoud F. Aliter
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 15, pp. 5224-5224
Open Access | Times Cited: 58
Expression of SARS-CoV-2-related receptors in cells of the neurovascular unit: implications for HIV-1 infection
Silvia Torices, Rosalba Cabrera, Michael Stangis, et al.
Journal of Neuroinflammation (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 55
Dipeptidyl peptidase-4 (DPP-4) inhibitor and mortality in coronavirus disease 2019 (COVID-19) – A systematic review, meta-analysis, and meta-regression
Iis Inayati Rakhmat, Yudith Yunia Kusmala, Dewi Ratih Handayani, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2021) Vol. 15, Iss. 3, pp. 777-782
Open Access | Times Cited: 53
Repurposing Known Drugs as Covalent and Non-covalent Inhibitors of the SARS-CoV-2 Papain-Like Protease
Pietro Delre, Fabiana Caporuscio, Michele Saviano, et al.
Frontiers in Chemistry (2020) Vol. 8
Open Access | Times Cited: 51
The Roles of Dipeptidyl Peptidase 4 (DPP4) and DPP4 Inhibitors in Different Lung Diseases: New Evidence
Tianli Zhang, Tong Xiang, Shijie Zhang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 49
Dipeptidyl peptidase 4 (DPP4) inhibitor and outcome from coronavirus disease 2019 (COVID-19) in diabetic patients: a systematic review, meta-analysis, and meta-regression
Timotius Ivan Hariyanto, Andree Kurniawan
Journal of Diabetes & Metabolic Disorders (2021) Vol. 20, Iss. 1, pp. 543-550
Open Access | Times Cited: 43
Role of genetic variants and host polymorphisms on COVID‐19: From viral entrance mechanisms to immunological reactions
Abolfazl Adli, Mandana Rahimi, Reza Khodaie, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 5, pp. 1846-1865
Open Access | Times Cited: 36
Obesity and COVID-19: Mechanistic Insights From Adipose Tissue
Lili Yu, Xiaoying Zhang, Sarah Ye, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 107, Iss. 7, pp. 1799-1811
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top